Last quarter (Q3 2023), PTC Therapeutics's total revenue was $196.58M, a decrease of -9.46% from the same quarter last year. In Q3, PTC Therapeutics's net income was $-113.98M. See PTC Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 758.96M	$ 698.80M	$ 538.59M	$ 380.77M	$ 306.98M	$ 264.73M
Cost of Revenue	$ -1.00M	$ -1.70M	$ -2.20M	$ 18.94M	$ 12.13M	$ 12.67M
Gross Profit	$ 798.18M	$ 698.80M	$ 538.59M	$ 361.82M	$ 294.85M	$ 252.06M
Operating Expense	$ 745.62M	$ -1.15B	$ -913.04M	$ 759.70M	$ 487.64M	$ 348.41M
Operating Income	$ -489.21M	$ -439.93M	$ -374.94M	$ -397.88M	$ -192.80M	$ -96.34M
Net Non Operating Interest Income Expense	$ -109.41M	$ -90.87M	$ -86.02M	$ -56.35M	$ -12.49M	$ -12.55M
Other Income Expense	$ 97.09M	$ 56.69M	$ 57.38M	$ 51.30M	$ -34.64M	$ -19.21M
Pretax Income	$ -728.75M	$ -587.49M	$ -518.34M	$ -402.93M	$ -239.93M	$ -128.11M
Tax Provision	$ -49.44M	$ -28.47M	$ 5.56M	$ 35.23M	$ 11.65M	$ -29.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -622.72M	$ -559.02M	$ -523.90M	$ -438.16M	$ -251.58M	$ -128.08M
Basic EPS	$ -8.65	$ -7.79	$ -7.43	$ -6.64	$ -4.27	$ -2.75
Diluted EPS	$ -8.16	$ -7.79	$ -7.43	$ -6.64	$ -4.27	$ -2.75
Basic Average Shares	$ 295.57M	$ 71.73M	$ 70.47M	$ 66.03M	$ 58.86M	$ 46.58M
Diluted Average Shares	$ 295.57M	$ 71.73M	$ 70.47M	$ 66.03M	$ 58.86M	$ 46.58M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 744.62M	$ -1.15B	$ 913.04M	$ 778.64M	$ 499.78M	$ 361.08M
Net Income From Continuing And Discontinued Operation	$ -641.70M	$ -559.02M	$ -523.90M	$ -438.16M	$ -251.58M	$ -128.08M
Normalized Income	$ -355.29M	-	-	$ -413.42M	$ -216.27M	$ -108.74M
Interest Expense	-	-	-	$ 56.35M	$ 12.49M	$ 12.55M
EBIT	$ -676.92M	$ -587.49M	$ -432.32M	$ -346.58M	$ -227.44M	$ -115.56M
EBITDA	$ -352.91M	$ -445.15M	$ -377.57M	$ -261.71M	$ -195.25M	$ -89.47M

Currency in USD

PTC Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing